Peripheral Neuropathy in Virologically Suppressed People Living with HIV: Evidence from the PIVOT Trial

The aim of this study is to identify the factors associated with peripheral neuropathy and to explore neurofilament light chain (NfL) as a biomarker for peripheral neuropathy (PN) in effectively virologically suppressed adults living with HIV. All protease inhibitor monotherapy versus ongoing triple...

Full description

Saved in:

Bibliographic Details
Published in:	Viruses Vol. 16; no. 1; p. 2
Main Authors:	Schuldt, Anna L., Bern, Henry, Hart, Melanie, Gompels, Mark, Winston, Alan, Clarke, Amanda, Chen, Fabian, Stöhr, Wolfgang, Heslegrave, Amanda, Paton, Nicholas I., Petzold, Axel, Arenas-Pinto, Alejandro
Format:	Journal Article
Language:	English
Published:	Switzerland MDPI AG 19.12.2023 MDPI
Subjects:	Adult Ankle biomarkers blood glucose Blood levels Blood pressure CD4 antigen CD4 lymphocyte count Complications and side effects Diabetes Diagnosis Drug resistance Drug therapy Fasting Female Glucose HIV HIV infection HIV infections HIV Infections - complications HIV Infections - drug therapy Human immunodeficiency virus Humans Male males Metabolic Syndrome monotherapy Neurotoxicity odds ratio Patient outcomes people Peripheral nerve diseases peripheral nervous system diseases Peripheral Nervous System Diseases - complications Peripheral neuropathy Plasma levels Population protease inhibitor Protease Inhibitors - therapeutic use Proteinase inhibitors Regression analysis risk Risk Factors standard deviation Statistical analysis therapeutics Toxicity Triglycerides United Kingdom metabolic syndrome protease inhibitor HIV peripheral neuropathy monotherapy
ISSN:	1999-4915, 1999-4915
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!